Identification of cell surface targets through meta-analysis of microarray data

Henry Haeberle1, Joel T Dudley, Jonathan T C Liu

  • 1Department of Pediatrics, Stanford University, Stanford, CA 94305, USA.

Neoplasia (New York, N.Y.)
|August 21, 2012
PubMed

Insights

Researchers identified novel cell surface biomarkers, fibrillin 2 and EphA3, for medulloblastoma using a bioinformatics approach. These markers can aid in developing molecular probes for precise surgical resection of pediatric brain tumors.

Area of Science:

  • Oncology
  • Bioinformatics
  • Molecular Biology

Background:

  • Precise surgical resection of medulloblastoma, a common pediatric brain cancer, is crucial for improving patient outcomes.
  • Current methods lack the molecular specificity and cellular resolution needed for complete tumor excision.
  • Development of molecular probes is essential for guided resection with high accuracy.

Purpose of the Study:

  • To develop a bioinformatics approach for identifying cell surface biomarkers highly enriched in medulloblastoma.
  • To discover novel molecular targets for developing probes to delineate medulloblastoma boundaries.
  • To enable image-guided surgical resection for improved cancer treatment.

Main Methods:

  • Analyzed microarray datasets to identify transcripts overexpressed in medulloblastoma compared to normal cerebellum.
  • Utilized gene ontology to filter for genes encoding proteins located on or within the plasma membrane, ensuring extracellular probe accessibility.
  • Validated top candidate biomarkers using immunohistochemistry.

Main Results:

  • Identified 380 genes with significantly higher expression in medulloblastoma versus cerebellum.
  • Refined the list to identify cell surface and extracellular proteins accessible to probes.
  • Validated fibrillin 2 and EphA3 as two specific biomarkers for medulloblastoma.

Conclusions:

  • A novel bioinformatics approach successfully identified accessible cell surface markers for medulloblastoma.
  • Fibrillin 2 and EphA3 are high-value targets for developing tumor-specific probes.
  • This method has broad applicability for identifying cancer biomarkers and enabling guided resection.